Kamada (XTAE:KMDA) Gross Margin % : 39.56% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Kamada Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Kamada's Gross Profit for the three months ended in Dec. 2023 was ₪53.6 Mil. Kamada's Revenue for the three months ended in Dec. 2023 was ₪135.4 Mil. Therefore, Kamada's Gross Margin % for the quarter that ended in Dec. 2023 was 39.56%.

The historical rank and industry rank for Kamada's Gross Margin % or its related term are showing as below:

XTAE:KMDA' s Gross Margin % Range Over the Past 10 Years
Min: 21.17 Med: 33.45 Max: 39.11
Current: 38.94

During the past 13 years, the highest Gross Margin % of Kamada was 39.11%. The lowest was 21.17%. And the median was 33.45%.

XTAE:KMDA's Gross Margin % is ranked worse than
64.44% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.705 vs XTAE:KMDA: 38.94

Kamada had a gross margin of 39.56% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Kamada was -0.20% per year.

Kamada Gross Margin % Historical Data

The historical data trend for Kamada's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kamada Gross Margin % Chart

Kamada Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

39.11

35.69

29.26

36.11

38.94

Kamada Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Margin %	Get a 7-Day Free Trial															33.65	38.55	38.55	39.02	39.56

Competitive Comparison of Kamada's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kamada's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kamada's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Kamada's Gross Margin % falls into.

Kamada Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Kamada's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	206.3	/	529.748
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(529.748 - 323.49)	/	529.748
	=	38.94 %

Kamada's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	53.6	/	135.419
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(135.419 - 81.849)	/	135.419
	=	39.56 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Kamada (XTAE:KMDA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Kamada had a gross margin of 39.56% for the quarter that ended in Dec. 2023 => Competition eroding margins

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Kamada Gross Margin % Related Terms

Thank you for viewing the detailed overview of Kamada's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kamada (XTAE:KMDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (XTAE:KMDA) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

KMDA:USA

Address

2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402

Website

https://www.kamada.com

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.